GlassScriptPhysician profile
Vu T Nguyen
NPI 1275530669
$4,116.25
in general payments reported to CMS, 2019-2025
18 companies · $659 in 2025
The $659 reported for 2025 was more than what 78% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $257 · 2020: $530 · 2021: $810 · 2022: $897 · 2023: $550 · 2024: $413 · 2025: $659.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,621.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,621.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,681.26 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Amgen INC. | $496.41 | 2021-2024 | Prolia, Evenity |
| Mylan Specialty L.P. | $304.66 | 2023-2024 | Yupelri |
| Glaxosmithkline, LLC. | $263.42 | 2022-2025 | Trelegy Ellipta |
| Amarin Pharma, INC. | $238.47 | 2021-2022 | |
| Gilead Sciences, INC. | $230.20 | 2020-2022 | |
| Novo Nordisk INC | $226.37 | 2022-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $143.73 | 2021-2025 | Zepbound, Mounjaro |
| Merck Sharp & Dohme LLC | $101.39 | 2020-2022 | |
| Exact Sciences Corporation | $80.06 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Kowa Pharmaceuticals America, INC. | $72.34 | 2024-2025 | Zoryve |
| Integra Lifesciences Corporation | $57.46 | 2023 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Smith+Nephew, INC. | $54.37 | 2019 | |
| Grifols USA, LLC | $49.31 | 2025 | Prolastin-C Liquid |
| Takeda Pharmaceuticals U.S.A., INC. | $42.41 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viatris Specialty LLC | $34.10 | 2025 | Yupelri |
| Pfizer INC. | $24.53 | 2021 | |
| Abbvie INC. | $15.76 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vu Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.